{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:44:32Z","timestamp":1775029472534,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000092","name":"National Library of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Objective: To compare 3 commercial knowledge bases (KBs) used for detection and avoidance of potential drug-drug interactions (DDIs) in clinical practice.<\/jats:p><jats:p>Methods: Drugs in the DDI tables from First DataBank (FDB), Micromedex, and Multum were mapped to RxNorm. The KBs were compared at the clinical drug, ingredient, and DDI rule levels. The KBs were evaluated against a reference list of highly significant DDIs from the Office of the National Coordinator for Health Information Technology (ONC). The KBs and the ONC list were applied to a prescription data set to simulate their use in clinical decision support.<\/jats:p><jats:p>Results: The KBs contained 1.6 million (FDB), 4.5 million (Micromedex), and 4.8 million (Multum) clinical drug pairs. Altogether, there were 8.6 million unique pairs, of which 79% were found only in 1 KB and 5% in all 3 KBs. However, there was generally more agreement than disagreement in the severity rankings, especially in the contraindicated category. The KBs covered 99.8\u201399.9% of the alerts of the ONC list and would have generated 25 (FDB), 145 (Micromedex), and 84 (Multum) alerts per 1000 prescriptions.<\/jats:p><jats:p>Conclusion: The commercial KBs differ considerably in size and quantity of alerts generated. There is less variability in severity ranking of DDIs than suggested by previous studies. All KBs provide very good coverage of the ONC list. More work is needed to standardize the editorial policies and evidence for inclusion of DDIs to reduce variation among knowledge sources and improve relevance. Some DDIs considered contraindicated in all 3 KBs might be possible candidates to add to the ONC list.<\/jats:p>","DOI":"10.1093\/jamia\/ocx010","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T13:26:51Z","timestamp":1485782811000},"page":"806-812","source":"Crossref","is-referenced-by-count":61,"title":["Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support"],"prefix":"10.1093","volume":"24","author":[{"given":"Kin Wah","family":"Fung","sequence":"first","affiliation":[{"name":"National Library of Medicine, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Kapusnik-Uner","sequence":"additional","affiliation":[{"name":"First Databank, South San Francisco, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, Greenwood Village, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Higby-Baker","sequence":"additional","affiliation":[{"name":"Cerner Multum, Denver, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bodenreider","sequence":"additional","affiliation":[{"name":"National Library of Medicine, Bethesda, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"issue":"1","key":"2020110612443628500_ocx010-B1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group","volume":"274","author":"Bates","year":"1995","journal-title":"JAMA."},{"key":"2020110612443628500_ocx010-B2","author":"Kohn","year":"2000"},{"issue":"1","key":"2020110612443628500_ocx010-B3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4338\/ACI-2010-04-RA-0026","article-title":"Towards meaningful medication-related clinical decision support: recommendations for an initial implementation","volume":"2","author":"Phansalkar","year":"2011","journal-title":"Applied clinical informatics."},{"issue":"7456","key":"2020110612443628500_ocx010-B4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"2020110612443628500_ocx010-B5","first-page":"210","article-title":"Polypharmacy and the risk of drug-drug interactions among Danish elderly. A prescription database study","volume":"45","author":"Rosholm","year":"1998","journal-title":"Danish medical bulletin."},{"issue":"2","key":"2020110612443628500_ocx010-B6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00228-014-1786-7","article-title":"Drug-drug interaction software in clinical practice: a systematic review","volume":"71","author":"Roblek","year":"2015","journal-title":"European journal of clinical pharmacology."},{"issue":"19","key":"2020110612443628500_ocx010-B7","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2146\/ajhp040567","article-title":"Assessment of potential drug-drug interactions with a prescription claims database","volume":"62","author":"Malone","year":"2005","journal-title":"Am J Health Syst Pharm."},{"issue":"9","key":"2020110612443628500_ocx010-B8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00228-007-0326-0","article-title":"Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register","volume":"63","author":"Astrand","year":"2007","journal-title":"European journal of clinical pharmacology."},{"key":"2020110612443628500_ocx010-B9"},{"issue":"4","key":"2020110612443628500_ocx010-B10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011","volume":"1;176","author":"Qato","year":"2016","journal-title":"JAMA internal medicine."},{"issue":"15","key":"2020110612443628500_ocx010-B11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ajhp\/56.15.1524","article-title":"Pharmacist recognition of potential drug interactions","volume":"56","author":"Weideman","year":"1999","journal-title":"Am J Health Syst Pharm."},{"key":"2020110612443628500_ocx010-B12"},{"key":"2020110612443628500_ocx010-B13"},{"issue":"6","key":"2020110612443628500_ocx010-B14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2125.2006.02809.x","article-title":"Comparative assessment of four drug interaction compendia","volume":"63","author":"Vitry","year":"2007","journal-title":"Br J Clin Pharmacol."},{"issue":"6","key":"2020110612443628500_ocx010-B15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11096-010-9445-2","article-title":"Evaluation of three brands of drug interaction software for use in intensive care units","volume":"32","author":"Reis","year":"2010","journal-title":"Pharm World Sci."},{"issue":"2","key":"2020110612443628500_ocx010-B16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1331\/154434504773062582","article-title":"Concordance of severity ratings provided in four drug interaction compendia","volume":"44","author":"Abarca","year":"2004","journal-title":"Journal of the American Pharmacists Association : JAPhA."},{"issue":"1","key":"2020110612443628500_ocx010-B17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1345\/aph.1M475","article-title":"Black box warning contraindicated comedications: concordance among three major drug interaction screening programs","volume":"44","author":"Wang","year":"2010","journal-title":"The Annals of pharmacotherapy."},{"issue":"1","key":"2020110612443628500_ocx010-B18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/clpt.2009.198","article-title":"Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia","volume":"87","author":"Olvey","year":"2010","journal-title":"Clinical pharmacology and therapeutics."},{"issue":"2","key":"2020110612443628500_ocx010-B19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1086-5802(16)31230-X","article-title":"Performance of community pharmacy drug interaction software","volume":"41","author":"Hazlet","year":"2001","journal-title":"J Am Pharm Assoc (Wash)."},{"issue":"10","key":"2020110612443628500_ocx010-B20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/11532340-000000000-00000","article-title":"Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US","volume":"33","author":"Smithburger","year":"2010","journal-title":"Drug Saf."},{"issue":"5","key":"2020110612443628500_ocx010-B21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.18553\/jmcp.2006.12.5.383","article-title":"Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies","volume":"12","author":"Abarca","year":"2006","journal-title":"J Manag Care Pharm."},{"issue":"3","key":"2020110612443628500_ocx010-B22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1460458207079836","article-title":"Evaluation of accuracy of drug interaction alerts triggered by two electronic medical record systems in primary healthcare","volume":"13","author":"Gaikwad","year":"2007","journal-title":"Health informatics journal."},{"key":"2020110612443628500_ocx010-B23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13326-015-0018-0","article-title":"Evaluating drug-drug interaction information in NDF-RT and DrugBank","volume":"6","author":"Peters","year":"2015","journal-title":"Journal of biomedical semantics."},{"key":"2020110612443628500_ocx010-B24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jbi.2015.04.006","article-title":"Toward a complete dataset of drug-drug interaction information from publicly available sources","volume":"55","author":"Ayvaz","year":"2015","journal-title":"J Biomed Inform."},{"issue":"11","key":"2020110612443628500_ocx010-B25","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1345\/aph.1P377","article-title":"Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings","volume":"44","author":"Smithburger","year":"2010","journal-title":"The Annals of pharmacotherapy."},{"issue":"1","key":"2020110612443628500_ocx010-B26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijmedinf.2009.09.003","article-title":"The state of the art in clinical knowledge management: an inventory of tools and techniques","volume":"79","author":"Sittig","year":"2010","journal-title":"Int J Med Inform."},{"issue":"6","key":"2020110612443628500_ocx010-B27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/jamia\/ocv011","article-title":"Recommendations to improve the usability of drug-drug interaction clinical decision support alerts","volume":"22","author":"Payne","year":"2015","journal-title":"J Am Med Inform Assoc."},{"issue":"2","key":"2020110612443628500_ocx010-B28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40264-014-0262-8","article-title":"Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support","volume":"38","author":"Scheife","year":"2015","journal-title":"Drug Saf."},{"issue":"2","key":"2020110612443628500_ocx010-B29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2146\/ajhp140095","article-title":"Reduction of clinical support warnings through recategorization of severity levels","volume":"72","author":"Parke","year":"2015","journal-title":"Am J Health Syst Pharm."},{"issue":"5","key":"2020110612443628500_ocx010-B30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/amiajnl-2011-000612","article-title":"High-priority drug-drug interactions for use in electronic health records","volume":"19","author":"Phansalkar","year":"2012","journal-title":"J Am Med Inform Assoc."},{"issue":"4","key":"2020110612443628500_ocx010-B31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson","year":"2011","journal-title":"J Am Med Inform Assoc."},{"key":"2020110612443628500_ocx010-B32"},{"key":"2020110612443628500_ocx010-B33"},{"key":"2020110612443628500_ocx010-B34"},{"key":"2020110612443628500_ocx010-B35"},{"issue":"8","key":"2020110612443628500_ocx010-B36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2146\/ajhp150565","article-title":"Recommendations for selecting drug-drug interactions for clinical decision support","volume":"73","author":"Tilson","year":"2016","journal-title":"Am J Health Syst Pharm."},{"issue":"12","key":"2020110612443628500_ocx010-B37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2165\/00002018-200528120-00007","article-title":"Clinical relevance of drug-drug interactions: a structured assessment procedure","volume":"28","author":"van Roon","year":"2005","journal-title":"Drug Saf."},{"key":"2020110612443628500_ocx010-B38","author":"Pharmacy Quality Alliance"}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/24\/4\/806\/34149424\/ocx010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jamia\/article-pdf\/24\/4\/806\/34149424\/ocx010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T01:08:07Z","timestamp":1658538487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article\/24\/4\/806\/3045119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,22]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,22]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jamia\/ocx010","relation":{},"ISSN":["1067-5027","1527-974X"],"issn-type":[{"value":"1067-5027","type":"print"},{"value":"1527-974X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7]]},"published":{"date-parts":[[2017,2,22]]}}}